Cervical cancer in India and HPV vaccination

Indian Journal of Medical and Paediatric Oncology

Volumn 33, Issue 1, 2012, Pages 7-12

  Kaarthigeyan, K ^a  

^a PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Cancer; cervix; human papillomavirus; vaccine

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ANUS CANCER; CANCER GROWTH; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CHLAMYDIA TRACHOMATIS; CONDYLOMA ACUMINATUM; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; ERYTHEMA; FOLLOW UP; HEALTH PROGRAM; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNE RESPONSE; IMMUNOGENICITY; INDIA; INFECTION PREVENTION; MIXED INFECTION; OROPHARYNX CANCER; PAIN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SEROTYPE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL STATUS; TREATMENT CONTRAINDICATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VAGINA CANCER; VIRUS PARTICLE; VIRUS STRAIN; VULVA CANCER;

EID: 84862537949     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.96961     Document Type: Review

References (30)

1. Schiffman M, Castle PE, Jeronim J, Rodrigue AC, Wacholde S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
2. Sankaranarayanan R, Ferlay J. Worldwide burden of gynecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25. (Pubitemid 43380597)
3. Singh N. HPV and Cervical cancer - prospects for prevention through vaccination. Indian J Med Paediatr Oncol 2005;26:20-3.
4. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India 2007. Available from: http://www.who.int/hpvcentre. [Last Assessed on 2008 May 1].
5. Howley PM, Lowy DR. Papillomaviruses and their replication, chapter 65. Field's Virology. In: Knipe DM, Howley PM, Editors. 4 th ed. Volume 2, Philadelphia: Lippincott Williamsand Wilkins; 2001. p. 2197-229.
6. Burd EM. Human Papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16:1-17. (Pubitemid 36114705)
7. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 2003;348:518-27. (Pubitemid 36159887)
8. World Health Organization. HPV IARC monograph summary. Lancet Oncol 2005;6:204.
9. Dunne EF, Markowitz LE. Genital human Papillomavirus infection. Clin Infect Dis 2006;43:624-9. (Pubitemid 44267125)
10. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911-9. (Pubitemid 30416152)
11. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-71. (Pubitemid 30451948)
12. Bosch FX, de Sanjosé SS. Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
13. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006;24: S1-10.
14. Castellsague X, Munoz N. Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-8.
15. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
16. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol 2001;2:27-32. (Pubitemid 33585914)
17. Huang CM. Human Papillomavirus and vaccination. Mayo Clin Proc 2008;83:701-7. (Pubitemid 351810571)
18. Singhal T. Indian Academy of Pediatrics Committee on Immunisation (IAPCOI) - Consensus Recommendations on Immunization 2008. Indian Pediatr 2008;45:635-48.
19. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human Papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8. (Pubitemid 40590263)
20. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with Human Papillomavirus types 16 and 18 in young women: A randomized controlled trial. Lancet 2004;364:1757-65. (Pubitemid 39488060)
21. Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56:(No. RR-2):1-32.
22. Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human Papillomavirus Types 6, 11, 16, and 18. Vaccine 2006;24:5571-83. (Pubitemid 44172918)
23. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006;95:1459-66. (Pubitemid 44863348)
24. Schiller JT, Frazer IH, Lowy DR. Human Papillomavirus vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. 5 th ed. Philadelphia: Saunders; 2008. p. 243-57.
25. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-24.
26. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2):1-24. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm. [Last Accessed on 2008 Apr 28].
27. American College of Obstetricians and Gynecologists. HPV Vaccine - ACOG Recommendations. Available from: http://www.acog.org/departments/dept-notice. cfm?recno=7andbulletin=3945. [Last Accessed on 2008, April 28].
28. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, et al. Gynaecologic Cancer Advisory Group. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28. (Pubitemid 46148088)
29. Choudhury P, John TJ. Human papilloma virus vaccines and current controversy. Indian Pediatr 2010;47:724-5.
30. Choudhury P, Yewale V. Human papilloma virus vaccines and current controversy-reply. Indian Pediatr 2011;48:248-9.